InsidersTradesSigma
Follow the 셀리드 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 셀리드 has recorded 4 public disclosures. Market capitalisation: €51.3bn. The latest transaction was reported on 6 May 2026 (Purchase). Among the most active insiders: 강창율. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
셀리드 operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the healthcare field.